Evolving Therapeutic Strategies in Advanced GI Cancers

Session Chair(s)

• RV

  Ruth Vera

Supported by Amgen

Presentations:

• 13:40 – 13:45

  Welcome and Introduction
  

  Session Chair: Ruth Vera
• 13:45 – 14:10

  Optimising anti-EGFR Therapy Across the Continuum of Care for RAS Wild-type Metastatic CRC
  

  Session Speaker: Dominik P. Modest
• 14:10 – 14:30

  A New ERA for KRAS-mutant GI Cancers
  

  Session Speaker: Hans Prenen
• 14:30 – 14:50

  Emerging Therapeutic Targets in Advanced Gastric Cancer
  

  Session Speaker: Elizabeth C. Smyth, MD – Cambridge University Hospitals, NHS Foundation Trust
• 14:50 – 15:10

  Panel Discussion and Q&A
  

  Session Moderator: Ruth Vera

  Session Panelist: Dominik P. Modest

  Session Panelist: Hans Prenen

  Session Panelist: Elizabeth C. Smyth, MD – Cambridge University Hospitals, NHS Foundation Trust